Similar articles

• [Importance of NOD2/CARD15 mutations in Crohn's disease].

  Mendoza Hernández JL, Lana Soto R, Díaz-Rubio García M. Mendoza Hernández JL, et al. Rev Clin Esp. 2004 Dec;204(12):642-4. doi: 10.1016/s0014-2565(04)71569-6. Rev Clin Esp. 2004. PMID: 15710072 Spanish. No abstract available.
• CARD15 and Crohn's disease.

  Peters KE, Cavanaugh JA. Peters KE, et al. J Gastroenterol Hepatol. 2004 Jul;19(7):830. doi: 10.1111/j.1440-1746.2004.03560.x. J Gastroenterol Hepatol. 2004. PMID: 15209636 No abstract available.
• CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins.

  Halfvarson J, Bresso F, D'Amato M, Järnerot G, Pettersson S, Tysk C. Halfvarson J, et al. Dig Liver Dis. 2005 Oct;37(10):768-72. doi: 10.1016/j.dld.2005.05.005. Dig Liver Dis. 2005. PMID: 16002353
• CARD15/NOD2 mutations in Crohn's disease.

  Hugot JP. Hugot JP. Ann N Y Acad Sci. 2006 Aug;1072:9-18. doi: 10.1196/annals.1326.011. Ann N Y Acad Sci. 2006. PMID: 17057186 Review.
• Slipping the barrier: how variants in CARD15 could alter permeability of the intestinal wall and population health.

  Schreiber S. Schreiber S. Gut. 2006 Mar;55(3):308-9. doi: 10.1136/gut.2005.076075. Gut. 2006. PMID: 16474103 Free PMC article. Review.